A detailed history of Fmr LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Fmr LLC holds 4,840,496 shares of IMCR stock, worth $187 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,840,496
Previous 4,817,699 0.47%
Holding current value
$187 Million
Previous $142 Million 1.05%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$28.21 - $33.0 $643,103 - $752,301
22,797 Added 0.47%
4,840,496 $144 Million
Q4 2024

Feb 13, 2025

SELL
$28.14 - $34.69 $516,115 - $636,249
-18,341 Reduced 0.38%
4,817,699 $142 Million
Q3 2024

Nov 13, 2024

BUY
$30.06 - $41.49 $704,486 - $972,359
23,436 Added 0.49%
4,836,040 $151 Million
Q2 2024

Aug 13, 2024

BUY
$33.78 - $63.75 $16.9 Million - $31.9 Million
500,460 Added 11.61%
4,812,604 $163 Million
Q1 2024

May 13, 2024

BUY
$60.14 - $75.36 $157 Million - $197 Million
2,615,758 Added 154.2%
4,312,144 $280 Million
Q4 2023

Feb 13, 2024

SELL
$42.85 - $69.5 $18.8 Million - $30.6 Million
-439,837 Reduced 20.59%
1,696,386 $116 Million
Q3 2023

Nov 13, 2023

BUY
$49.5 - $66.6 $4.46 Million - $6 Million
90,116 Added 4.4%
2,136,223 $111 Million
Q2 2023

Aug 11, 2023

SELL
$48.54 - $61.64 $2.11 Million - $2.68 Million
-43,444 Reduced 2.08%
2,046,107 $123 Million
Q1 2023

May 11, 2023

BUY
$46.12 - $65.71 $3.95 Million - $5.63 Million
85,638 Added 4.27%
2,089,551 $103 Million
Q4 2022

Feb 13, 2023

BUY
$45.51 - $65.08 $27.8 Million - $39.7 Million
610,679 Added 43.83%
2,003,913 $114 Million
Q3 2022

Nov 10, 2022

BUY
$37.34 - $57.44 $1.23 Million - $1.89 Million
32,850 Added 2.41%
1,393,234 $65.4 Million
Q2 2022

Aug 12, 2022

SELL
$25.46 - $37.72 $6.8 Million - $10.1 Million
-267,171 Reduced 16.42%
1,360,384 $50.8 Million
Q1 2022

May 13, 2022

SELL
$18.94 - $34.29 $9.39 Million - $17 Million
-495,772 Reduced 23.35%
1,627,555 $48.7 Million
Q4 2021

Feb 14, 2022

SELL
$27.58 - $40.0 $1.59 Million - $2.31 Million
-57,659 Reduced 2.64%
2,123,327 $72.7 Million
Q3 2021

Nov 15, 2021

BUY
$27.98 - $40.0 $26.6 Million - $38 Million
949,142 Added 77.05%
2,180,986 $80.8 Million
Q2 2021

Aug 13, 2021

BUY
$32.22 - $41.5 $39.7 Million - $51.1 Million
1,231,844 New
1,231,844 $48.1 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.7B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.